Diligence memo · auto-generated · as of July 2, 2026

Augustine Surgical, Inc.

Augustine Surgical, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Augustine Surgical, Inc. operates in Medical Devices, based in EDEN PRAIRIE.

Sub-sector tags: medical-devices.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Augustine Surgical, Inc. has raised $1.5M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $1.0M on 2019-07-15.

Most recent recorded round closed around 2019-07-15.

Valuation (modeled)modeled

Provath models Augustine Surgical, Inc. at approximately $37M (range $600K–$418M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 5.00× the median modeled value of Pre-Seed Medical Devices companies in 2019–2021 (26 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 14 months.

Last raise 7.0 yr ago; this sector typically re-raises about every 16 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 2.1× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 47% of Medical Devices peers (233 compared).

Modeled value ranks above 72% of those peers.

Closest niche peers: White Mountain Surgical Partners, LLC, Irving Specialists Surgical Center LLC, Grand Parkway Surgical Institute LLC, Halo Diagnostics Llc, West Texas Surgical Services, LLC.

Peoplefiled

9 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.